Medpace Inventory Falls On This autumn Earnings: The Particulars – Medpace Hldgs (NASDAQ:MEDP)

Medpace Holdings Inc MEDP reported fourth-quarter monetary outcomes after the market shut on Monday. Right here’s a rundown of the report.

• This autumn Income: $536.6 million, versus estimates of $534.78 million

• This autumn EPS: $3.67, versus estimates of $2.96

Whole income was up 7.7% on a year-over-year foundation. New enterprise awards totaled $529.7 million within the quarter, down 13.8% year-over-year. The corporate ended the interval with a backlog of roughly $2.9 billion, up 3.2% year-over-year.

Medpace generated $190.7 million in money circulation from operations in the course of the quarter. The corporate had money and money equivalents of $669.4 million as of Dec. 31.

Medpace mentioned it repurchased $174.2 million of its widespread inventory in the course of the quarter. The corporate had $134.6 million remaining beneath its buyback at quarter’s finish. Moreover, Medpace’s board authorized a rise of $600 million to the corporate’s buyback program on Feb. 6.

Examine This Out: Lattice Semiconductor Shares Soar After Combined This autumn Outcomes, Robust Q1 Steerage

Outlook: Medpace expects full-year 2025 income to be within the vary of $2.11 billion to $2.21 billion. The corporate sees full-year earnings within the vary of $11.93 per share to $12.69 per share.

Medpace executives will additional focus on the quarter on a name with traders and analysts at 9 a.m. ET Tuesday morning.

MEDP Value Motion: At publication time Monday, Medpace shares had been down 8.33% at $324.97 in after-hours buying and selling, in accordance with Benzinga Professional.

Picture: Shutterstock.